We are live on
!
Find out more
Alnylam Pharmaceuticals
ALNY
ALNY
292 hedge funds and large institutions have $10.9B invested in Alnylam Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 114 increasing their positions, 83 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
38% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 34
37% more repeat investments, than reductions
Existing positions increased: 114 | Existing positions reduced: 83
4% more funds holding
Funds holding: 282 → 292 (+10)
3% more call options, than puts
Call options by funds: $109M | Put options by funds: $105M
2.24% less ownership
Funds ownership: 93.75% → 91.51% (-2.2%)
7% less capital invested
Capital invested by funds: $11.7B → $10.9B (-$792M)
14% less funds holding in top 10
Funds holding in top 10: 14 → 12 (-2)
Holders
292
Holders Change
+10
Holders Change %
+3.55%
% of All Funds
6.69%
Holding in Top 10
12
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-14.29%
% of All Funds
0.28%
New
47
Increased
114
Reduced
83
Closed
34
Calls
$109M
Puts
$105M
Net Calls
+$3.5M
Net Calls Change
-$17.1M
Top Buyers
Top Sellers
| 1 |
Dodge & Cox
San Francisco,
California
|
-$456M |
| 2 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$35.2M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$29.4M |
| 4 |
Goldman Sachs
New York
|
-$22.8M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$15.5M |
